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Two different methods were evaluated for incorporating [‘251]cholesteryl iopanoate ([‘251]CI), a 
non-hydrolyzable cholesteryl ester analog, into LDL. The first procedure was an organic solvent 
delipidation-reconstitution procedure (R[‘251-CI]LDL) while the second involved incubation of detergent 
(Tween-20)~solubilized [iz51]CI with whole plasma (D[1251-CI]LDL). R[1251-CI]LDL behaved similar to 
native LDL in vitro, but was markedly different in viuo, apparently due to a heterogeneity in particle size. 
D[‘251-CI]LDL, however, was metabolized normally both in vitro and in vim. These results, combined with 
the residualizing nature of [‘251]CI, demonstrate that D[‘251-CI]LDL is appropriate for tracing LDL uptake 
in vivo. 
Introduction 
Study of the disposition of low density lipoprotein 
(LDL)-associated cholesteryl esters (CE) in vim is 
complicated by the fact that, once cellular uptake 
occurs, the lipoprotein constituents are rapidly de- 
graded. The free cholesterol arising from hydrolysis 
of the CE can then either undergo re-esterification 
and remain within the cell as stored cholesteryl ester 
(Goldstein and Brown, 1977) or it can redistribute to 
other tissues. This process has particularly hampered 
biodistribution studies, which are essential in evaluat- 
ing the alterations in sites of CE uptake accompany- 
ing hypercholesterolemia and treatment with 
lipid-lowering drugs. For this reason, several investi- 
gators have directed their efforts toward developing 
LDL preparations labeled with radiotracers which 
residualize in the tissues. Notable examples of LDL 
labeled on the protein moiety include p”Tc]LDL 
(Lees et al., 1985; Fischman et al., 1987) and 
[1251]tyramine cellobiose-LDL (Pittman et al., 1983). 
Comparatively little progress, however, has been 
made with respect to the development of radio- 
labeled, non-degradable CE analogs. One compound 
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of this type is [3H]cholesteryl linoleyl ether, which has 
been used by Stein and coworkers in a variety of 
studies (Halperin et al., 1986). Alternatively, 
[“‘I]cholesteryl iopanoate ([‘z51]CI) (Fig. l), a CE 
analog used in several studies in our laboratory, has 
properties which demonstrate its utility as a tracer for 
lipoprotein metabolism in uivo. First, the compound 
is quite stable to degradation in viuo (Seevers et al., 
1982; DeGalan et al., 1986), and its uptake into 
tissues has been found to be highly correlated with 
the tissue CE content (DeGalan et al., 1985; DeForge 
et al., 1989). In addition, the y-emitting isotope 
simplifies its quantitation in tissue samples and also 
permits non-invasive assessment of the biodistribu- 
tion of radioactivity using nuclear medicine imaging 
techniques such as gamma camera scintigraphy 
(Counsel1 et al., 1989; DeGalan et al., 1988; DeForge 
et al., 1989). Lastly, recent studies in our laboratory 
have shown [‘25 I]CI to be a poor substrate for human, 
rabbit, and guinea pig lipid transfer protein (LTP), 
with a rate of transfer 5-l 5% that of [3 Hlcholesteryl 
oleate (manuscript in preparation). Although this 
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Fig. 1. Structure of cholesteryl iopanoate. Radioiodine is 
introduced by an exchange reaction with Na[‘251]. 
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incorporate [‘*‘I]CI into LDL, it also increases 
the likelihood that, after injection into animals, 
the [‘251]CI will remain associated with the 
injected LDL without rapidly redistributing 
among the endogenous lipoproteins. 
In these studies, [‘251]CI was incorporated 
into LDL by two different procedures not re- 
quiring LTP involvement. In vitro and in vivo 
analyses were then used to evaluate the simi- 
larity of the resulting preparations to native 
LDL. 
Materials and Methods 
Isolation of low density Iipoprotein 
Human LDL. Blood (500 mL) freshly drawn from 
normal human volunteers was obtained from the 
University of Michigan Hospital apheresis clinic, and 
a preservative cocktail was added (Edelstein and 
Scanu, 1986). Plasma was obtained by low speed 
centrifugation at 4°C and LDL was isolated between 
the densities of 1.020 and 1.063 g/mL as previously 
described (Have1 et al., 1955) using a Beckman L8-80 
ultracentrifuge and a 60Ti rotor. The LDL was 
dialyzed against 4 x 4 L phosphate-buffered saline 
(PBS) containing 0.01% EDTA and sterilized by 
passage through a 0.22 pm filter. The protein content 
was determined by the method of Lowry et al. (1951) 
using bovine serum albumin (BSA) as a standard. 
Guinea pig LDL. Male guinea pigs (350-400g) 
were obtained from Hazelton Research Laboratories 
(Denver, Pa). Blood from 4 to 6 animals was drawn 
from the right atrium into syringes containing preser- 
vatives (Edelstein and Scanu, 1986). The blood was 
pooled, and the procedure described for the isolation 
of human LDL was then followed, with the exception 
that the fraction between the densities of 1.020 and 
1.100 g/mL was harvested as LDL (Guo et af., 1977). 
LDL labeling procedures 
Radioiodination of LDL. Human and guinea pig 
LDL were radioiodinated as previously described 
(Goldstein et al., 1983) using Na[‘*‘I] obtained from 
ICN (Irvine, Calif.). After dialysis against at least 4 
changes of buffer (4 L 0.9% NaCl, 1.5 mM EDTA, 
pH 7.2), greater than 97% of the [12jI]LDL radio- 
activity was precipitable by 12% trichloroacetic acid 
(TCA) and less than 10% of the radioactivity was 
extractable in chloroform/methanol (2: 1). Specific 
activities ranged between 120 and 600dpm/ng 
protein. 
Reconstitution of LDL. Human and guinea pig 
LDL were reconstituted essentially as described by 
Krieger et al. (1978). Briefly, 1.9 mg LDL protein and 
25 mg potato starch were mixed in siliconized test 
tubes, lyophilized overnight, and delipidated with 
ice-cold heptane over a 1.5 h incubation period at 
-20°C. The desired mixture of lipids in hexane 
(<5OOpL, see below) was then added to the 
LDL/starch matrix. Following a 1 h incubation at 
- 20°C the solvent was completely evaporated under 
N, at 0°C and 1 mL 10 mM Tricine buffer (pH 8.4) 
was added to each test tube. The reconstituted 
LDL was separated from the starch by low speed 
centrifugation after an overnight incubation at 
4°C. Aliquots were analyzed for radioactivity using 
either a TM Analytic (model 1185) or Micromedic 
Systems MACC y-counter. Protein concentrations 
were determined as described (Lowry er a/., 1951). 
The [‘*‘I]CI was synthesized and radiolabeled 
as previously described (Seevers et al., 1982) to 
obtain specific activities ranging between 0.2 and 
1.7 Ci/mmol. Its radiochemical purity was checked 
prior to use by thin layer chromatography in a 
hexane/ethyl acetate (5 : 2) solvent system using 
Eastman silica gel chromatographic sheets. 
LDL was reconstituted with cholesteryl oleate 
(CO, Sigma Chemical Co.) mixed with tracer quan- 
tities of [‘251]CI. Because preliminary studies indi- 
cated that reconstitution of LDL with 2mg of the 
[‘*‘I]CI/CO mixture per 1.9 mg LDL protein yielded 
a preparation with highest specific activity and 
greatest uptake into fibroblasts, this ratio was used 
in subsequent studies. As assessed by the analyses 
described below, the [‘251]CI-reconstituted LDL was 
essentially identical to a control preparation of LDL 
reconstituted with [3 Hlcholesteryl linoleate, using 
6 mg total CE per 1.9 mg LDL protein as described 
by Krieger et al. (1978). 
Because of its ready availability, human LDL was 
used for several studies involving the in vitro charac- 
terization of reconstituted LDL. Preparations of 
reconstituted guinea pig LDL, which were also 
characterized in vitro to ensure their biologic validity, 
were used for all in vivo studies. The results of the 
reconstitution were essentially identical regardless of 
the species origin of the LDL. Average protein and 
radioactivity recoveries were 45 and 36%, respect- 
ively, and specific activities ranged from 40 to 
120 dpm/mg depending on the specific activity and 
quantity of [‘251]CI used per reconstitution. Reconsti- 
tuted human and guinea pig LDL will be denoted as 
R[‘*‘I-CI]LDL and R[‘25 I-CI]gpLDL, respectively, 
when the distinction is necessary. 
Incorporation of detergent-solubilized [‘“I]CI into 
LDL. [‘*‘I]CI was formulated by adding Tween-20 
(100 pL/mg compound) to the [‘251]CI dissolved in 
hexane/ethyl acetate (19 : 1). After vortexing 
thoroughly, the solvents were evaporated under a 
slow stream of nitrogen. Saline was then added such 
that the Tween-20 constituted <3% of the final 
volume. The mixture was vortexed thoroughly again 
and placed briefly under nitrogen to remove any 
residual solvents. Samples were taken for determi- 
nation of radioactivity content. Guinea pig plasma 
was obtained as described above, and an aliquot of 
the formulated [‘*‘I]CI was added to a IO-fold greater 
volume of plasma. The mixture was then incubated 
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at 37°C with gentle agitation. A preliminary time- 
course study demonstrated maximal association of 
[‘251]CI with the LDL fraction was achieved by a 2-h 
incubation period. This incubation time was used for 
all further studies. The [‘2SI]CI-labeled LDL fraction 
(D[‘251-CI]gpLDL) was then isolated from the plasma 
by ultracentrifugation as described above. The 
D[‘251-CI]gpLDL was then dialyzed against 4 x 4 L 
PBS, and aliquots were analyzed for protein (Lowry 
et al., 1951) and radioactivity. Recoveries of protein 
and radioactivity were greater than 90% and approx. 
60%, respectively, and specific activities ranged be- 
tween 30 and 45 dpm/ng protein. Although this pro- 
cedure has also been used to label human LDL, it was 
particularly successful for guinea pig LDL (in terms 
of [“‘I]CI recovery) due to the predominance of this 
lipoprotein fraction in the plasma. 
Characterization 
Column chromatography. Samples of the various 
LDL preparations were adjusted to 10% w/v sucrose, 
applied to a 2.6 x 90 cm column of 6% agarose 
(Bio-Gel A-5 m, 200-400 mesh, Bio-Rad Labora- 
tories, Richmond, Calif.) (Rude1 et al., 1974), and 
eluted with sterile 0.9% NaCl/O.Ol% EDTA at 4°C. 
Fractions (100 x 250 drops) were collected under 
gravity flow (approx. 0.35 mL/min). The eluant was 
monitored for absorbance at 280 nm, and aliquots of 
each fraction were taken for determination of radio- 
activity content. For samples of reconstituted LDL, 
the fractions representing peaks of protein and radio- 
activity were pooled, put into dialysis tubing (mol- 
ecular weight cutoff, 12,000) and concentrated in 
polyvinyl pyrrolidone (Sigma Chemical Co.). After 
dialyzing against several 4 L changes of PBS, the 
protein (Lowry et al., 1951) and radioactivity content 
of each of the peaks were determined as above. 
Electrophoresis. In order to assess the integrity of 
apo B-100, all LDL samples were analyzed by sodium 
dodecyl sulfate (SDS)-PAGE on 3-20% acrylamide 
gradient slab gels essentially as described (Cardin 
et al., 1986). The gels were stained by heating for 2 h 
in a solution of 0.1% Coomassie Blue G-250/50% 
acetic acid/lo% methanol, destained in 10% acetic 
acid/lo% methanol, and scanned with a Zeineh soft 
laser scanning densitometer (Biomed Instruments 
Inc., Fullerton, Calif.). 
Fibroblust uptake studies. Cell uptake was exam- 
ined using both normal human fibroblasts (N-l) 
and fibroblasts derived from a patient with familial 
hypercholesteremia (GM- 19 15, Human Genetic 
Mutant Cell Repository, Camden, N.J.) as previously 
described (DeForge et al., 1991). The radiolabelled 
LDL preparations were added at a concentration of 
10 pg/mL, and the plates were incubated at 37°C for 
6 h. Uptake was examined both in the absence and in 
the presence of a 20-fold excess of competing native 
LDL. The cell-associated radioactivity for all samples 
was determined by counting NaOH cell digests 
(DeForge et al., 1991). The media from cells incu- 
bated with [12’I]LDL was analyzed for radioactivity 
corresponding to degraded apoprotein (Drevon et al., 
1981). Total uptake of [‘251]LDL (expressed as ng 
LDL bound, internalized, and degraded per mg cell 
protein) was then calculated from the cell-associated 
radioactivity and the radioactivity in the media corre- 
sponding to degraded LDL. Over the 6 h time period 
studied, efflux of radiolabeled degradation products 
from cells incubated with the [‘251]CI-labeled LDL 
preparations did not occur to a significant extent 
(< 3% of the total uptake). For these preparations, 
“ng LDL/mg cell protein” represents binding and 
internalization of the lipoprotein as calculated from 
cell-associated radioactivity. 
Plasma clearance and tissue distribution studies 
Male guinea pigs (450-55Og) were anesthetized 
with xylazine (9mg) and ketamine (30mg), and the 
right carotid artery of each animal was cannulated 
essentially as described (Latham, 1977; DeForge 
et al., 1991). The radiolabeled guinea pig LDL prep- 
arations (1.1-8.6 pCi per animal) were then adminis- 
tered and blood samples (0.5 mL) were withdrawn via 
the cannula at 0.25, 0.5, 1, 2, 4 and 6 h post-injection 
from conscious, restrained animals (DeForge et al., 
1991). The plasma was immediately separated from 
each blood sample and duplicate aliquots were 
counted for radioactivity to allow for calculation of 
the percent injected dose present in the plasma at each 
time point. Each of the plasma samples was also 
analyzed in duplicate by electrophoresis on 3% acryl- 
amide gels (Narayan, 1975). The gels were cut accord- 
ing to the lipoprotein banding pattern (Narayan, 
1975) and counted to determine the percent radio- 
activity co-migrating with the LDL fraction. Animals 
were killed 24 h post-injection, and a blood sample 
was obtained and processed as above. In addition, 
several tissues were removed and whole organ 
weights were obtained where appropriate. Duplicate 
samples of tissue minces were then placed in gelatin 
capsules, weighed, and counted for radioactivity. 
From this data, the percent injected dose per gram of 
tissue was calculated and then multiplied by the 
weight of the animal in kilograms [% (kg) dose/g]. 
This expression facilitates comparison between ani- 
mals by eliminating variability in the data caused by 
differences in body weights. 
Data analysis 
The fractional catabolic rates (FCR) of the guinea 
pig LDL preparations were calculated using a kinetic 
model (Langer et al., 1972) originally described by 
Matthews (1957). Student’s t-test was used to assess 
the significance of the differences between the groups. 
Size distribution 
Results 
Upon chromatographic analysis using a 6% 
agarose column, radioiodinated LDL ([‘251]LDL) 
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Fig. 2. Elution profiles of [‘251]gpLDL (A), R[‘251-CI]- 
gpLDL (B) and D[‘*51-CI]gpLDL (C) from a gel filtration 
column of 6% agarose. The profile of radioactivity is shown 
and closely corresponded with the U.V. absorbance profile. 
eluted as a single, symmetrical peak of protein and 
radioactivity [Fig. 2(A)]. In contrast, similar analysis 
of R[‘251-CI]LDL resolved the preparation into three 
peaks of protein and radioactivity (P, , P,, and P3) 
[Fig. 2(B)], which corresponded in size to very low 
density lipoprotein (VLDL), intermediate density 
lipoprotein (IDL), and LDL, respectively. The frac- 
tions constituting each peak were pooled and con- 
centrated for further analysis. The elution profile of 
D[‘25 I-CI]gpLDL showed that this preparation was 
essentially homogeneous in size, but contained a 
small shoulder of larger molecular weight material 
[Fig. 2(C)]. In addition, as compared to the 
[I25 I]gpLDL control, the D[‘25 I-CI]gpLDL peak 
eluted from the column a few fractions earlier than 
that of [‘251]LDL, indicating a slight increase in 
particle size. 
Analysis of apo B- 100 integrity 
Because it was unclear what effect the labeling 
procedures had on the integrity of apo B-100, 
delipidated samples of LDL labeled with [“‘I]CI by 
both procedures were analyzed by SDS-PAGE on 
3320% acrylamide gradient gels. Both preparations 
were essentially identical to control samples of native 
LDL and [‘25 I]LDL with respect to the appearance of 
the apo B-100 band and the absence of bands corre- 
sponding to degradation products (data not shown). 
The three column-derived fractions of the R[“‘I- 
CI]LDL were also analyzed with similar results, thus 
indicating that neither the reconstitution procedure 
nor the column fractionation and concentration 
procedures adversely affected protein integrity. 
As a means of assessing the receptor-recognition 
capability of apo B-100, cell culture studies were 
conducted in which the uptake of the [‘251]CI-labeled 
preparations was compared to that of a [12’I]LDL 
control preparation in two lines of human fibroblasts. 
The N-l cell line expresses the LDL receptor and 
metabolizes LDL normally, while the GM-1915 
cell line, obtained from a patient with homozygous 
familial hypercholesterolemia, does not express the 
LDL receptor. 
The results of one such study are shown in Fig. 3 
with uptake of the [‘251]CI-labeled preparations being 
expressed as a percentage of the [‘251]LDL control. 
The uptake observed in the N-l cell line was sub- 
stantially reduced by the presence of competing LDL, 
and was similarly low in the LDL receptor-negative 
cell line (GM-1915). These results indicate that 
uptake into the normal cells was largely due to 
an LDL receptor-mediated process. Uptake of 
R[‘251-CI]LDL, P,, and P, were not significantly 
different from that of the [‘251]LDL control, while 
that of P, was lower by approx. 50% (P < 0.001). In 
this instance, human LDL was used for both the 
reconstituted LDL preparations and the [‘251]LDL 
control. Similar results were observed for guinea pig 
LDL. 
Uptake of D[‘251-CI]gpLDL was also examined 
in the human fibroblast system, and its uptake is 
expressed as the percentage of a [125 I]gpLDL control 
(Fig. 3). Due to the difference in the species origin of 
the LDL and the fibroblasts, the uptake of both 
guinea pig LDL preparations was approx. 60% lower 
than that observed for corresponding preparations of 
human LDL but was nonetheless characteristic of an 
LDL receptor-mediated process. In this particular 
experiment, uptake of the D[‘251-CI]gpLDL prep- 
aration was slightly higher than that of the 
[‘2SI]gpLDL control. 
Plasma clearance of [‘2sI]CI-labeled guinea pig LDL 
Each of the [‘251]CI-labeled guinea pig LDL 
preparations (R[‘251-CI]gpLDL, P,, P,, P,, and 
D[‘251-CI]gpLDL) was injected into 3-4 normal male 
guinea pigs, and the plasma levels of radioactivity 
were assessed at several time points over a 24 h time 
period. An additional group of animals was injected 
with [“‘I]gpLDL. The results, expressed as percent 
injected dose remaining in the plasma, are shown 
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Fig. 3. Fibroblast uptake of R[‘251-CI]hLDL, P,, P,, P,, and D[‘251-CI]gpLDL. Both normal (N-l) and 
LDL receptor-negative (GM-1915) fibroblasts were incubated with each of the lipoprotein preparations 
at a concentration of 10 pg/mL for 6 h in the presence and in the absence of 200 pgg/mL competing native 
LDL. Results are expressed as the percent of control uptake (either [‘251]LDL or [‘251]gpLDL). The error 
bars represent the SEM of triplicate determinations. 
in Fig. 4. It can be seen that the plasma clearance 
of D[‘251-CI]gpLDL was quite similar to that 
of [‘251]gpLDL. The FCRs were 0.131 + 0.008 
and 0.120 f 0.011 h-’ for D[“‘I-CI]gpLDL and 
[‘251]gpLDL, respectively (mean f SEM). The plasma 
decay curves of all reconstituted preparations, how- 
ever, were markedly different. All of these curves were 
characterized by an initial rapid disappearance of the 
injected dose from the plasma followed by a rate of 
clearance which was considerably slower than that of 
the [‘251]gpLDL control. These abnormalities became 
more pronounced with increasing particle size. The 
FCRs of P, and R[‘251-CI]gpLDL were substantially 
higher than that of [‘251]gpLDL [O. 178 f 0.032 and 
0.236 + 0.062 h-‘, respectively (mean + SEM)]. FCR 
values were not calculated for P, and P’. 
The plasma samples obtained at each time point 
were also analyzed by 3% PAGE to determine the 
distribution of radioactivity in the various lipoprotein 
fractions. For [‘25 I]gpLDL, D[“‘I-CI]gpLDL, 
R[‘251-CI]gpLDL, and PJ, 70-85% of the plasma 
radioactivity at each time point migrated electrophor- 
etically in association with the LDL fraction. For P, 
and P,, this value was somewhat lower (40-60%) 
since a portion of these larger-sized particles migrated 
in the size range of VLDL and IDL. 
Tissue distribution of radioactivity 
All guinea pigs used in the clearance 
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Fig. 4. Time-course of clearance of radioactivity from the plasma of guinea pigs injected with [‘25i]gpLDL 
(n = 4), D[‘251-CI]gpLDL, R[i2’ I-CI]gpLDL (n = 4) P, (n = 3), P, (n = 3), and P, (n = 3). The percent 
injected dose remaining in the plasma was calculated at each time point, with the values representing 
mean f SEM. 
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Fig. 5. Tissue distribution of radioactivity in selected tissues 24 h after injection of guinea pigs with 
[‘251]gpLDL (n = 4) R[‘2sI-CI]gpLDL (n = 3), and D[“‘I-CI]gpLDL (n = 3). The data are expressed as 
the percent injected dose recovered per gram of tissue multipled by the weight of the animal in kilograms. 
Values represent mean + SEM for the indicated number of animals. 
analyzed for radioactivity. These included organs 
such as heart, lung, spleen, and testes, as well as bile 
and duodenum (indicative of excretion of free 
[‘2sI]iopanoic acid into the biliary tree), abdominal 
fat, and skeletal muscle, all of which contained low 
levels of radioactivity. The major sites of accumu- 
lation of radioactivity, however, were the adrenal 
and liver, tissues expressing the largest numbers of 
LDL receptors, and the thyroid and urine, sites of 
accumulation of radioactive degradation products. 
The results for these tissues are shown in Fig. 5 
expressed in terms of % (kg) dose per gram of tissue. 
Comparison of the results of the two [‘2SI]CI-labeled 
LDL preparations shows that adrenal radio- 
activity was higher for the D[‘*‘I-CI]gpLDL group, 
while liver radioactivity was higher for the 
R[‘251-CI]gpLDL group. These differences were not 
unexpected considering the more rapid clearance of 
R[‘*‘I-CI]gpLDL and the possible contribution of 
reticuloendothelial cell uptake to the liver radio- 
activity value. A more striking difference, however, 
was evident upon comparison of the [‘*‘I]CI groups 
to the group injected with [‘*‘I]gpLDL. The adrenal 
and liver radioactivity of the [‘*‘I]gpLDL group was 
substantially lower while the thyroid and urine radio- 
activity was several-fold higher. The tissue distri- 
bution of P, , P,, and P, was generally similar to that 
of R[‘*‘I-CI]gpLDL with the exception that adrenal 
uptake was lower by 22-57% (data not shown). 
Discussion 
Two different procedures for incorporating [‘251]CI 
into LDL were compared for their ability to result in 
a lipoprotein that is metabolically similar to native 
LDL both in vitro and in vivo. The first method was 
a delipidation-reconstitution procedure (Krieger 
et al., 1978). This method has been successful with a 
variety of lipophilic molecules (Krieger et al., 
1979a, b), it allows the potential for high specific 
labeling of LDL, and it has been shown to result in 
a particle similar to native LDL in vitro (Krieger 
et aI., 1978). An alternative procedure involving 
incubation of detergent-solubilized [‘*‘I]CI with 
whole plasma was also examined. [‘*‘I]CI was readily 
incorporated into LDL via either method. Although 
it is not possible to state whether the [‘251]CI resides 
in the lipid core of the LDL preparations resulting 
from these two procedures, [1251]CI remained firmly 
associated with the intact LDL molecule when the 
preparations were subjected to gel filtration chroma- 
tography and to electrophoresis on 3% acrylamide 
gels. It is known that endogenous CE partition 
between the surface and core lipids according to their 
hydrophobicity, and it is reasonable to speculate that 
this would also be true of [‘*‘I]CI. Both methods, 
however, caused some perturbation in the size distri- 
bution of the LDL preparation. This was much more 
severe for the reconstituted LDL and may have 
resulted from clumping or fusion of the particles 
during the delipidation procedure. Nonetheless, both 
R[‘*‘I-CI]gpLDL and D[‘*‘I-CI]gpLDL were shown 
to be suitable for use in in vitro studies in that neither 
the integrity of apo B-100 nor the extent of receptor- 
mediated fibroblast uptake was altered. However, 
because subtle alterations in LDL may not be 
detected by in vitro systems (Witztum et al., 198.5) 
in vivo studies were undertaken using the guinea pig 
as a model of LDL metabolism. This species is 
well-suited for lipoprotein metabolic studies (Witz- 
turn et al., 1985; Luc and Chapman, 1988) with the 
LDL fraction comprising 70-80% of the plasma 
cholesterol (Spady et al., 1983; Sardet et al., 1972). 
The results of the plasma clearance study dramati- 
cally illustrated the marked differences in the metab- 
olism of the two preparations. While the plasma 
[‘2SI]Cholesteryl iopanoate-labeling of LDL 781 
clearance rates of the R[‘25 I-CI]gpLDL preparation iopanoate as a potential probe for the in vivo visualization 
and the chromatographically-separated size fractions of atherosclerotic lesions in animals. Pharmaceut. Res. 3, __ _ _ 
were markedly abnormal,~ the clearance rate of 52-55. 
D[tZ51-CI]gpLDL was not significantly different from 
DeGalan M. R., Schwendner S. W., Skinner R. W., Longino 
that of the ]1251]gpLDL control. Furthermore, the 
M. A., Gross M. D. and Counsel1 R. E. (1988) Iodine-125 
cholestervl ionanoate for measuring extent of athero- _ _-_ 
advantage of using LDL labeled with a residualizing sclerosis In rabbits. J. Nucl. Med. 29, 503-508. 
tracer such as [‘25I]CI as opposed to radioiodinated Drevon C. A., Attie A. D., Pangburn S. H. and Steinberg 
LDL was readily apparent from the results of the 
D. (1981) Metabolism of homologous and heterologous 
tissue distribution study. In previous studies in which 
lipoproteins by cultured rat and human skin fibroblasts. 
J. Lipid Res. 22, 37-46. 
saline-solubilized [12’ I]CI was injected into guinea Edelstein C. and Scanu A. M. (1986) Precautionary 
pigs, TLC analysis of extracts of adrenal and liver measures for collecting blood destined for lipoprotein 
samples demonstrated that greater than 80% of the 
isolation. Methods Enzymol. 128, 151-I 55. 
radioactivity was still associated with the parent 
Fischman A. J., Lees A. M., Lees R. S., Barlai-Kovach M. 
and Strauss H. W. (1987) Accumulation of native and 
compound 24 h post-injection (unpublished results). methylated low density lipoproteins by healing rabbit 
The longtetm stability of [‘25I]CI in other species arterial wall. Arteriosclerosis 129, 361-366. 
has also been documented (DeForge et al., 1989; Goldstein J. L. and Brown M. S. (1977) The low-density 
DeGalan et al., 1986; Seevers et al., 1982). Moreover, 
lipoprotein pathway and its relation to atherosclerosis. 
the low levels of thyroid and urine radioactivity 
Ann. Rev. Biochem. 46, 897-930. 
Goldstein J. L.. Basu S. K. and Brown M. S. (1983) 
demonstrated that the comnound. with the radio- Recentor-mediated endocvtosis of low-density linonroteiu 
iodine placed on an aromatic group, was also quite in cuhured cells. Methods Enzymol. 98, 241:260.- 
resistant to deiodination. 
Guo L. S. S., Meng M., Hamilton R. L. and Ostwald R. 
In conclusion, D[‘25 I-CI]gpLDL represents a suit- 
(1977) Changes in the plasma lipoprotein-apoproteins of 
able probe for tracing uptake of LDL-associated CE 
guinea pigs in response to dietary cholesterol. Biochem- 
istry 16, 5806-58 12. 
in guinea pigs. This preparation has potential appli- Halpdrin G., Stein 0. and Stein Y. (1986) Synthesis of 
cations for studying the changes in the sites of ether analogs of lipoprotein lipids and their biological 
CE uptake accompanying hypo- and hypercholes- 
application. Methods Enzymol. 129, 816-848. 
terolemia, adrenal dysfunction, and atherosclerosis. 
Have1 R. J., Eder H. A. and Bragdon J. H. (1955) The 
distribution and chemical comoosition of ultracentrifu- 
gaily separated lipoproteins in’ human serum. J. Clin. 
Acknowledgements-The authors gratefully acknowledge Invest. 34, 1345-1353. 
the expert -technical advice and instruction-of Dr Thomas Krieger M., Brown M. S., Faust J. R. and Goldstein J. L. 
Bocan. MS Erika Fercuson. MS Karen Kieft. MS Catherine (1978) Replacement of endoaenous cholesteryl esters of 
Sekerke, and Mr Pail Uhiendorf. This research was sup- iow den&y lipoprotein with exogenous -cholesteryl 
ported by grants from the National Institutes of Health linoleate. Reconstitution of a biologically active particle. 
(CA-08349) the American Heart Association of Michigan, J. Biol. Chem. 253, 4093-4101. 
and by a National Institutes of Health Pharmacological Krieger M., McPhaul M. J., Goldstein J. L. and Brown 
Sciences Training Grant (T32-07767). M. S. (1979a) Replacement of neutral lipids of low density 
lioonroteins with esters of lone chain unsaturated fattv 
References 
. 
acids. J. Biol. Chem. 254, 384;3853. 
Krieger M., Smith L. C., Anderson R. G. W., Goldstein 
Cardin A. D., Price C. A., Hirose N., Krivanek M. A., 
Blankenship D. T., Chao J. and Mao S. J. T. (1986) 
Structural organization of apolipoprotein B-100 of 
human plasma low density lipoproteins. Comparsion to 
B-48 of chylomicrons and very low density lipoproteins. 
J. Biol. Chem. 261, 16,744-16,748. 
Counsel1 R. E., Schwendner S. W., Gross M. D., Longino 
M. A. and McConnell D. S. (1989) Lipoprotein incorpor- 
ation enhances radioiodinated cholesteryl ester uptake 
into steroid hormone-secreting tissues. J. Nucl. Med. 30, 
1088-1094. 
DeForge L. E., Ruyan M. K., Schwendner S. W., Newton 
R. S. and Counsel1 R. E. (1991) Synthesis and evaluation 
of radioiodinated cholesteryl ethers as lipoprotein probes. 
Bioconjug. Chem. 2, 254-260. 
DeForge L. E., Schwendner S. W., DeGalan M. R., 
McConnell D. S. and Counsel1 R. E. (1989) Noninvasive 
assessment of lipid disposition in treated and untreated 
atherosclerotic rabbits. Pharmaceut. Res. 6, 101 l-1016. 
DeGalan M. R., Schwendner S. W., Gross M. D. and 
Counsel1 R. E. (1985) Assessment of the antiatherogenic 
efficacy of a hypolipidemic drug by scintigraphy. In 
Current Applications in Radiopharmacology. Proceedings 
of the Fourth International Symposium on Radiopharma- 
cology (Edited by Billinghurst M. W.), pp. 109-I 17. 
Pergamon Press, New York. 
DeGalan M. R., Schwendner S. W., Weichert J. P. 
and Counsel1 R. E. (1986) Radioiodinated cholesteryl 
J. L., Kao Y. J., Pownall H. J., Gotto A. M. Jr and Brown 
M. S. (1979b) Reconstituted low density lipoprotein: a 
vehicle for the delivery of hydrophobic fluorescent probes 
to cells. J. Supramol. Srrucr. 10, 467-478. 
Langer T., Strober W. and Levy R. I. (1972) The metab- 
olism of low density lipoprotein in familial type II hyper- 
lipoproteinemia. J. Clin. Invest. 51, 152881536. 
Latham A. N. (1977) A new chronically cannulated carotid 
artery preparation for determination of drug half-lives in 
guinea pig. Can. J. Physiol. Pharmacol. 55, 773-777. 
Lees R. S., Garabedian H. D., Lees A. M., Schumacher 
D. J., Miller A., Isaacsohn J. L., Derksen A. and Strauss 
H. W. (1985) Technetium-99m low density lipoproteins: 
preparation and biodistribution. J. Nucl. Med. 26, 
1056-1062. 
Lowry 0. H., Rosebrough N. J., Farr A. L. and Randall R. 
J. (1951) Protein measurement with the Folin phenol 
reagent. J. Biol. Chem. 193, 265-275. 
Luc G. and Chapman M. J. (1988) Guinea pig low density 
lipoproteins: structural and metabolic heterogeneity. 
J. Lipid Res. 29, 1251-1263. 
Matthews C. M. E. (1957) The theory of tracer experiments 
with r3’I-labelled plasma proteins. Phys. Med. Biol. 2, 
36-53. 
Narayan K. A. (1975) Electrophoretic methods for the 
separation of serum lipoproteins. In Analysis of Lipids 
and Lipoproreins (Edited by Perkins E. G.), pp. 225-249. 
The American Oil Chemists Society, Champaign, Ill. 
782 LAURA E. DEFORGE et al 
Pittman R. C., Carew T. E., Glass C. K., Green S. R., Seevers R. H., Groziak M. P., Weichert J. P., Schwendner 
Taylor C. A. and Attie A. D. (1983) A radioiodinated, S. W., Szabo S. M., Longino M. A. and Counsel1 R. E. 
intracellularly trapped ligand for determining the sites of (1982) Potential tumor- or organ-imaging agents. 23. 
plasma protein degradation in ~iuo. Biochem. J. 212, Sterol esters of iopanoic acid. J. Med. Chem. 25, 
791-800. 1500-1503. 
Rude1 L. L., Lee J. A., Morris M. D. and Felts J. M. (1974) 
Characterization of plasma lipoproteins separated and 
purified by agarose-column chromatography. Biochem. J. 
139, 89-95. 
Sardet C., Hansma H. and Ostwald R. (1972) Characteriz- 
ation of guinea pig plasma lipoproteins: the appearance 
of new lipoproteins in response to dietary cholesterol. 
J. Lipid Res. 13, 624-639. 
Spady J. M. and Dietschy J. M. (1983) Sterol synthesis 
in vioo in 18 tissues of the squirrel monkey, guinea pig, 
rabbit, hamster, and rat. J. Lipid Res. 24, 303-315. 
Witztum J. L., Young S. G., Elam R. L., Carew 
T. E. and Fisher M. (1985) Cholestyramine-induced 
changes in low density lipoprotein composition and 
metabolism. I. Studies in the guinea pig. J. Lipid Res. 26, 
92-103. 
